tiprankstipranks
Advertisement
Advertisement

RPRX Stock Latest News

Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
The FlyRoyalty Pharma price target raised to $64 from $63 at Morgan Stanley
13d ago
RPRX
Royalty Pharma price target raised to $58 from $50 at JPMorgan
PremiumThe Fly
Royalty Pharma price target raised to $58 from $50 at JPMorgan
13d ago
RPRX
Royalty Pharma price target raised to $66 from $50 at Citi
PremiumThe Fly
Royalty Pharma price target raised to $66 from $50 at Citi
13d ago
RPRX
Royalty Pharma’s Earnings Call Signals Confident Growth
PremiumCompany Announcements
Royalty Pharma’s Earnings Call Signals Confident Growth
14d ago
RPRX
Royalty Pharma price target raised to $57 from $51 at UBS
PremiumThe Fly
Royalty Pharma price target raised to $57 from $51 at UBS
29d ago
RPRX
Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside
PremiumRatingsRoyalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside
29d ago
RPRX
Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone
Premium
Company Announcements
Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone
1M ago
8K
RPRX
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
Premium
The Fly
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
1M ago
RPRX
Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
PremiumThe Fly
Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
2M ago
JNJ
RPRX
Zymeworks price target raised to $48 from $33 at Evercore ISI
PremiumThe Fly
Zymeworks price target raised to $48 from $33 at Evercore ISI
2M ago
RPRX
ZYME
Royalty Pharma appoints Kenneth Sun as Senior Vice President, Head of Asia
PremiumThe Fly
Royalty Pharma appoints Kenneth Sun as Senior Vice President, Head of Asia
3M ago
RPRX
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
PremiumThe Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
3M ago
ONC
JAZZ
Royalty Pharma price target raised to $50 from $45 at TD Cowen
PremiumThe FlyRoyalty Pharma price target raised to $50 from $45 at TD Cowen
3M ago
RPRX
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
3M ago
J
W
Royalty Pharma Earnings Call Balances Strength And Risk
Premium
Company Announcements
Royalty Pharma Earnings Call Balances Strength And Risk
3M ago
RPRX
Royalty Pharma price target raised to $51 from $45 at Goldman Sachs
PremiumThe Fly
Royalty Pharma price target raised to $51 from $45 at Goldman Sachs
3M ago
RPRX
Royalty Pharma price target raised to $61 from $56 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $61 from $56 at Morgan Stanley
3M ago
RPRX
Royalty Pharma sees FY26 portfolio receipts $3.275B-3.425B
PremiumThe Fly
Royalty Pharma sees FY26 portfolio receipts $3.275B-3.425B
3M ago
RPRX
Royalty Pharma reports Q4 portfolio receipts of $874M
PremiumThe Fly
Royalty Pharma reports Q4 portfolio receipts of $874M
3M ago
RPRX
Royalty Pharma PLC (RPRX) Q4 Earnings Cheat Sheet
PremiumPre-EarningsRoyalty Pharma PLC (RPRX) Q4 Earnings Cheat Sheet
3M ago
RPRX
Royalty Pharma upgraded to Buy from Neutral at UBS
Premium
The Fly
Royalty Pharma upgraded to Buy from Neutral at UBS
4M ago
RPRX
Royalty Pharma price target raised to $50 from $48 at Citi
Premium
The Fly
Royalty Pharma price target raised to $50 from $48 at Citi
4M ago
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >